Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
One Johnson & Johnson Plaza New Brunswick, NJ, 08933
Trial results for the COVID-19 vaccine candidate developed by Johnson & Johnson (NYSE:JNJ) are reportedly expected to be released soon. The Hill reported last week that former FDA Commissioner Scott Gottlieb said the single-dose vaccine from J&J subsidiary Janssen Pharmaceutical appears to have a “good profile for a vaccine,” indicating the potential for a third authorized…
Trial results for the COVID-19 vaccine candidate developed by Johnson & Johnson (NYSE:JNJ) are reportedly expected to be released soon. The Hill reported last week that former FDA Commissioner Scott Gottlieb said the single-dose vaccine from J&J appears to have a “good profile for a vaccine,” indicating the potential for a third authorized candidate, following those […]
Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices. Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, […]
The news was nonstop in 2020 and surprisingly, it wasn’t all related to the COVID-19 pandemic. There was plenty of other medtech news, including information about new technologies, new products, new companies — and a sneak preview of what to expect in 2021. The editors at Medical Design & Outsourcing decided to share the most-read…
COVID-19 dominated the news, but there was so much more going on in medtech. Let’s face it: These are soul-trying times, and no one is going to miss 2020. We’re leaving behind a year of tragedy and disaster — with the COVID-19 pandemic and its more than 1.6 million deaths (more than 300,000 in the…